Clinical Trial Update: To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial update for generic calcipotriene and betamethasone dipropionate topical suspension in scalp psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scalp Psoriasis

Drugs mentioned

• Calcipotriene and betamethasone dipropionate topical suspension, 0.005%/0.064%

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Scalp Psoriasis | Phase 3 | Status: COMPLETED